| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.26 | 4e-07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.061 | 0.3 |